EMAIL THIS PAGE TO A FRIEND

Biotechnology and bioengineering

Three dimensional multi-cellular muscle-like tissue engineering in perfusion-based bioreactors.


PMID 26126766

Abstract

Conventional tissue engineering strategies often rely on the use of a single progenitor cell source to engineer in vitro biological models; however, multi-cellular environments can better resemble the complexity of native tissues. Previous described co-culture models used skeletal myoblasts, as parenchymal cell source, and mesenchymal or endothelial cells, as stromal component. Here, we propose instead the use of adipose tissue-derived stromal vascular fraction cells, which include both mesenchymal and endothelial cells, to better resemble the native stroma. Percentage of serum supplementation is one of the crucial parameters to steer skeletal myoblasts toward either proliferation (20%) or differentiation (5%) in two-dimensional culture conditions. On the contrary, three-dimensional (3D) skeletal myoblast culture often simply adopts the serum content used in monolayer, without taking into account the new cell environment. When considering 3D cultures of mm-thick engineered tissues, homogeneous and sufficient oxygen supply is paramount to avoid formation of necrotic cores. Perfusion-based bioreactor culture can significantly improve the oxygen access to the cells, enhancing the viability and the contractility of the engineered tissues. In this study, we first investigated the influence of different serum supplementations on the skeletal myoblast ability to proliferate and differentiate during 3D perfusion-based culture. We tested percentages of serum promoting monolayer skeletal myoblast-proliferation (20%) and differentiation (5%) and suitable for stromal cell culture (10%) with a view to identify the most suitable condition for the subsequent co-culture. The 10% serum medium composition resulted in the highest number of mature myotubes and construct functionality. Co-culture with stromal vascular fraction cells at 10% serum also supported the skeletal myoblast differentiation and maturation, hence providing a functional engineered 3D muscle model that resembles the native multi-cellular environment.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

HPA002951
Anti-CSPG4 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
HPA042785
Anti-CSPG4 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB4300397
Anti-MYOD1 (Ab-200) antibody produced in rabbit, affinity isolated antibody
SAB2105139
Anti-MYOD1 antibody produced in rabbit, affinity isolated antibody
SAB1410813
Anti-MYOD1 antibody produced in rabbit, purified immunoglobulin, buffered aqueous solution
SAB2102034
Anti-RNF5 antibody produced in rabbit, affinity isolated antibody
SAB4200208
Anti-RNF5 antibody produced in rabbit, ~1.0 mg/mL, affinity isolated antibody
SAB2701502
Anti-RNF5 antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB1408906
Anti-VCAN antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
HPA004726 Anti-VCAN antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
M6190 Monoclonal Anti-MYOD1 antibody produced in mouse, clone 5.2F, purified immunoglobulin, buffered aqueous solution
WH0004654M1
Monoclonal Anti-MYOD1 antibody produced in mouse, clone 1A7, purified immunoglobulin, buffered aqueous solution
SAB5300415
Monoclonal Anti-MYOD1 antibody produced in mouse, clone 1C8, ascites fluid
N8912 Monoclonal Anti-NG2 antibody produced in mouse, clone 132.38, purified immunoglobulin, buffered aqueous solution